First results of a phase I/II dose escalation trial in non-small cell lung cancer using three-dimensional conformal radiotherapy

Radiotherapy and Oncology

Volumn 66, Issue 2, 2003, Pages 119-126

  Belderbos, José S A ^a   De Jaeger, Katrien ^a   Heemsbergen, Wilma D ^a   Seppenwoolde, Yvette ^a   Baas, Paul ^a   Boersma, Liesbeth J ^a   Lebesque, Joos V ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

Conformal radiotherapy; Dose escalation; Lung cancer; Mean lung dose; Radiation pneumonitis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DOSIMETRY; ESOPHAGUS; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MAXIMUM TOLERATED DOSE; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIATION PNEUMONIA; RADIATION RESPONSE; RISK; SAFETY; TOXICITY; TREATMENT OUTCOME;

EID: 0037296426     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(02)00377-8     Document Type: Article

References (32)

1. Arriagada R., Le Chevalier T., Quoix E., et al. ASTRO (American Society for Therapeutic Radiology and Oncology) plenary: effect of chemotherapy on locally advanced non-small cell lung carcinoma: a randomized study of 353 patients. Int J Radiat Oncol Biol Phys. 20:1991;1183-1190.
2. Bel A., van Herk M., Bartelink H., Lebesque J.V. A verification procedure to improve patient set-up accuracy using portal images. Radiother Oncol. 29:1993;253-260.
3. Belderbos J.S., Lebesque J.V., Barillot I. Normal tissue complication probabilities for irradiation of NSCLC patients with and without elective nodal irradiation. Lung Cancer. S18:1997;126.
4. Cox J.D., Pajak T.F., Asbell S., et al. Interruptions of high-dose radiation therapy decrease long-term survival of favorable patients with unresectable non-small cell carcinoma of the lung: analysis of 1244 cases from 3 Radiation Therapy Oncology Group (RTOG) trials. Int J Radiat Oncol Biol Phys. 27:1993;493-498.
5. Engelsman M., Remeijer P., van Herk M., Mijnheer B.J., Damen E.M. The theoretical benefit of beam fringe compensation and field size reduction for ISO-NTCP dose escalation in radiotherapy of lung cancer. Med Phys. 2002;. submitted.
6. Erridge S.C., Seppenwoolde Y., Muller S.H., et al. Portal imaging to assess setup errors, tumor motion and tumor shrinkage during conformal radiotherapy of non-small cell lung cancer. Radiother Oncol. 2002;. in press.
7. Fowler J.F., Chappell R. Non-small cell lung tumors repopulate rapidly during radiation therapy. Int J Radiat Oncol Biol Phys. 46:2000;516-517.
8. Graham M.V., Winter K., Purdy J.A., et al. Preliminary Results of a Radiation Threrapy Oncology Group trial (RTOG 9311). A dose escalation study using 3D conformal radiation therapy in patients with inoperable nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys. 51:(Suppl 1):2001;S19.
9. Green M.R., Cox J.D., Ardizzoni A., et al. Endpoints for multimodal clinical trials in stage III non-small cell lung cancer (NSCLC): a consensus report. Lung Cancer. 11:(Suppl 3):1994;S11-S13.
10. Hayman J.A., Martel M.K., Ten Haken R.K., et al. Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial. J Clin Oncol. 19:2001;127-136.
11. Prescribing, recording, and reporting photon beam therapy. ICRU Report. 1993;ICRU, Washington, dc.
12. Krol A.D., Aussems P., Noordijk E.M., Hermans J., Leer J.W. Local irradiation alone for peripheral stage I lung cancer: could we omit the elective regional nodal irradiation? Int J Radiat Oncol Biol Phys. 34:1996;297-302.
13. Kutcher G.J., Burman C. Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method. Int J Radiat Oncol Biol Phys. 16:1989;1623-1630.
14. Kwa S.L., Lebesque J.V., Theuws J.C., et al. Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys. 42:1998;1-9.
15. Lebesque J.V., Keus R.B. The simultaneous boost technique: the concept of relative normalized total dose. Radiother Oncol. 22:1991;45-55.
16. Leibel S.A., Kutcher G.J., Mohan R., et al. Three-dimensional conformal radiation therapy at the Memorial Sloan-Kettering Cancer Center. Semin Radiat Oncol. 2:1992;274-289.
17. Lyman J.T. Complication probability as assessed from dose-volume histograms. Radiat Res Suppl. 8:1985;S13-S19.
18. Martel M.K., Sahijdak W.M., Hayman J.A., Ball D. Incidental dose to clinically negative nodes from conformal treatment fields for non small cell lung cancer. Int J Radat Oncol Biol Phys. 45:1999;244.
19. Martel M.K., Ten Haken R.K., Hazuka M.B., et al. Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients. Lung Cancer. 24:1999;31-37.
20. McGibney C., Holmberg O., McClean B., et al. Dose escalation of chart in non-small cell lung cancer: is three- dimensional conformal radiation therapy really necessary? Int J Radiat Oncol Biol Phys. 45:1999;339-350.
21. Mehta M., Scrimger R., Mackie R., et al. A new approach to dose escalation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 49:2001;23-33.
22. Meijer G.J., Bruinvis I.A., Mijnheer B.J., Lebesque J.V. A treatment planning method to correct dose distributions distorted by setup verification fields. Int J Radiat Oncol Biol Phys. 46:2000;1319-1328.
23. Noordijk E.M., vd Poest Clement E., Hermans J., Wever A.M., Leer J.W. Radiotherapy as an alternative to surgery in elderly patients with resectable lung cancer. Radiother Oncol. 13:1988;83-89.
24. Pieterman R.M., van Putten J.W., Meuzelaar J.J., et al. Preoperative staging of non-small-cell lung cancer with positron-emission tomography. N Engl J Med. 343:2000;254-261.
25. Robertson J.M., Ten Haken R.K., Hazuka M.B., et al. Dose escalation for non-small cell lung cancer using conformal radiation therapy. Int J Radiat Oncol Biol Phys. 37:1997;1079-1085.
26. Rosenzweig K.E., Sim S.E., Mychalczak B., et al. Elective nodal irradiation in the treatment of non-small-cell lung cancer with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys. 50:2001;681-685.
27. Saunders M., Dische S., Barrett A., et al. Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. CHART Steering committee. Radiother Oncol. 52:1999;137-148.
28. Schaake-Koning C., van den Bogaert W., Dalesio O., et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med. 326:1992;524-530.
29. Sibley G.S., Jamieson T.A., Marks L.B., Anscher M.S., Prosnitz L.R. Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience. Int J Radiat Oncol Biol Phys. 40:1998;149-154.
30. Theuws J.C., Muller S.H., Seppenwoolde Y., et al. Effect of radiotherapy and chemotherapy on pulmonary function after treatment for breast cancer and lymphoma: a follow-up study. J Clin Oncol. 17:1999;3091-3100.
31. van Herk M., Kooy H.M. Automatic three-dimensional correlation of CT-CT, CT-MRI, and CT-SPECT using chamfer matching. Med Phys. 21:1994;1163-1178.
32. Vansteenkiste J.F., Stroobants S.G., De Leyn P.R., et al. Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients. J Clin Oncol. 16:1998;2142-2149.